John Kappler
Concepts (933)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes | 239 | 2021 | 2012 | 5.950 |
Why?
| | Receptors, Antigen, T-Cell | 125 | 2024 | 677 | 5.650 |
Why?
| | Histocompatibility Antigens Class II | 80 | 2021 | 365 | 5.290 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 64 | 2024 | 330 | 4.850 |
Why?
| | CD4-Positive T-Lymphocytes | 55 | 2024 | 1150 | 3.850 |
Why?
| | Major Histocompatibility Complex | 56 | 2024 | 234 | 3.640 |
Why?
| | Thymus Gland | 59 | 2024 | 310 | 2.560 |
Why?
| | Peptide Fragments | 24 | 2021 | 693 | 2.420 |
Why?
| | Peptides | 48 | 2021 | 992 | 2.390 |
Why?
| | Hybridomas | 74 | 2019 | 233 | 2.280 |
Why?
| | Lymphocyte Activation | 81 | 2020 | 1137 | 2.040 |
Why?
| | Antigens | 50 | 2021 | 350 | 1.850 |
Why?
| | Histocompatibility Antigens | 17 | 2019 | 102 | 1.740 |
Why?
| | Mice | 331 | 2024 | 18297 | 1.730 |
Why?
| | Epitopes, T-Lymphocyte | 9 | 2021 | 175 | 1.630 |
Why?
| | H-2 Antigens | 38 | 2011 | 111 | 1.510 |
Why?
| | B-Lymphocytes | 61 | 2017 | 887 | 1.490 |
Why?
| | Animals | 371 | 2024 | 38107 | 1.450 |
Why?
| | Autoantigens | 23 | 2021 | 426 | 1.360 |
Why?
| | Amino Acid Sequence | 72 | 2019 | 2092 | 1.340 |
Why?
| | Epitopes | 47 | 2021 | 479 | 1.280 |
Why?
| | Autoimmunity | 13 | 2021 | 925 | 1.270 |
Why?
| | Berylliosis | 10 | 2021 | 204 | 1.200 |
Why?
| | Molecular Sequence Data | 68 | 2015 | 2838 | 1.120 |
Why?
| | Protein Binding | 36 | 2021 | 2244 | 1.090 |
Why?
| | Enterotoxins | 26 | 2009 | 89 | 1.080 |
Why?
| | Models, Molecular | 29 | 2018 | 1574 | 1.080 |
Why?
| | Antigen Presentation | 17 | 2021 | 209 | 1.070 |
Why?
| | Autoimmune Diseases | 7 | 2021 | 467 | 1.060 |
Why?
| | Immune Tolerance | 31 | 2024 | 386 | 1.050 |
Why?
| | Histocompatibility Antigens Class I | 12 | 2018 | 207 | 0.970 |
Why?
| | Immunologic Memory | 26 | 2020 | 369 | 0.930 |
Why?
| | Beryllium | 8 | 2021 | 163 | 0.930 |
Why?
| | Diabetes Mellitus, Type 1 | 16 | 2021 | 3930 | 0.930 |
Why?
| | Antibodies, Monoclonal | 55 | 2020 | 1512 | 0.900 |
Why?
| | Baculoviridae | 9 | 2015 | 44 | 0.890 |
Why?
| | HLA-DP beta-Chains | 10 | 2021 | 88 | 0.860 |
Why?
| | Alleles | 13 | 2017 | 907 | 0.860 |
Why?
| | CD8-Positive T-Lymphocytes | 24 | 2021 | 931 | 0.850 |
Why?
| | Insulin | 11 | 2024 | 2525 | 0.830 |
Why?
| | Interleukin-2 | 37 | 2015 | 434 | 0.800 |
Why?
| | Superantigens | 18 | 2002 | 70 | 0.770 |
Why?
| | Antigens, Surface | 24 | 2011 | 155 | 0.710 |
Why?
| | Mice, Inbred C57BL | 102 | 2024 | 6034 | 0.710 |
Why?
| | Mice, Transgenic | 48 | 2024 | 2134 | 0.700 |
Why?
| | Cell Line | 41 | 2021 | 2814 | 0.670 |
Why?
| | Lysosomes | 2 | 2021 | 134 | 0.660 |
Why?
| | Cathepsins | 1 | 2021 | 24 | 0.660 |
Why?
| | Antigens, Neoplasm | 8 | 2021 | 271 | 0.650 |
Why?
| | HLA-DR Antigens | 9 | 2016 | 211 | 0.650 |
Why?
| | Peptide Library | 6 | 2013 | 91 | 0.630 |
Why?
| | T-Lymphocyte Subsets | 19 | 2013 | 416 | 0.630 |
Why?
| | Protein Conformation | 21 | 2018 | 916 | 0.620 |
Why?
| | Adjuvants, Immunologic | 12 | 2016 | 245 | 0.610 |
Why?
| | Flow Cytometry | 28 | 2015 | 1163 | 0.590 |
Why?
| | Islets of Langerhans | 4 | 2021 | 852 | 0.570 |
Why?
| | Immunoglobulin G | 10 | 2017 | 901 | 0.560 |
Why?
| | Genes, MHC Class II | 18 | 2014 | 77 | 0.560 |
Why?
| | Base Sequence | 36 | 2016 | 2123 | 0.560 |
Why?
| | Mammary Tumor Virus, Mouse | 12 | 1995 | 42 | 0.540 |
Why?
| | Chromogranin A | 2 | 2015 | 43 | 0.520 |
Why?
| | Binding Sites | 20 | 2021 | 1309 | 0.500 |
Why?
| | Membrane Proteins | 14 | 2020 | 1130 | 0.500 |
Why?
| | Mice, Inbred BALB C | 48 | 2021 | 1244 | 0.500 |
Why?
| | Amino Acids | 5 | 2022 | 515 | 0.490 |
Why?
| | Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 4 | 2012 | 27 | 0.480 |
Why?
| | Mice, Inbred NOD | 11 | 2020 | 598 | 0.480 |
Why?
| | Ikaros Transcription Factor | 2 | 2013 | 23 | 0.470 |
Why?
| | Antigen-Presenting Cells | 21 | 2015 | 161 | 0.460 |
Why?
| | Proto-Oncogene Proteins | 12 | 2009 | 616 | 0.460 |
Why?
| | Lymphocyte Cooperation | 21 | 1990 | 50 | 0.460 |
Why?
| | Complementarity Determining Regions | 8 | 2012 | 54 | 0.450 |
Why?
| | Immunity, Cellular | 16 | 2010 | 277 | 0.450 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 96 | 0.440 |
Why?
| | CD3 Complex | 10 | 2018 | 113 | 0.440 |
Why?
| | Alum Compounds | 6 | 2016 | 26 | 0.440 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 12 | 2007 | 237 | 0.440 |
Why?
| | Hypersensitivity | 3 | 2016 | 253 | 0.430 |
Why?
| | Evolution, Molecular | 4 | 2019 | 502 | 0.430 |
Why?
| | Histone Demethylases | 3 | 2020 | 39 | 0.420 |
Why?
| | bcl-2-Associated X Protein | 4 | 2006 | 53 | 0.410 |
Why?
| | Gene Expression Regulation | 22 | 2015 | 2599 | 0.410 |
Why?
| | Immunoglobulin Variable Region | 11 | 2012 | 78 | 0.410 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 18 | 1991 | 106 | 0.410 |
Why?
| | Antibody Formation | 21 | 2010 | 290 | 0.400 |
Why?
| | Thymoma | 5 | 2012 | 38 | 0.400 |
Why?
| | Mice, Inbred Strains | 36 | 2000 | 384 | 0.400 |
Why?
| | Mutation | 25 | 2022 | 4093 | 0.390 |
Why?
| | Apoptosis | 15 | 2011 | 2439 | 0.390 |
Why?
| | Conserved Sequence | 3 | 2009 | 242 | 0.390 |
Why?
| | Lymphocytes, Null | 1 | 2012 | 3 | 0.380 |
Why?
| | Spleen | 32 | 2016 | 503 | 0.380 |
Why?
| | Lymphokines | 12 | 1984 | 127 | 0.380 |
Why?
| | HLA-DR4 Antigen | 2 | 2005 | 74 | 0.380 |
Why?
| | Bacterial Toxins | 6 | 1997 | 110 | 0.380 |
Why?
| | Crystallography, X-Ray | 10 | 2018 | 477 | 0.370 |
Why?
| | Antigens, Viral | 10 | 2001 | 186 | 0.360 |
Why?
| | Protein Processing, Post-Translational | 8 | 2018 | 487 | 0.360 |
Why?
| | Apoptosis Regulatory Proteins | 10 | 2011 | 186 | 0.360 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 129 | 0.360 |
Why?
| | Protein Structure, Tertiary | 10 | 2021 | 834 | 0.360 |
Why?
| | Ligands | 13 | 2022 | 678 | 0.350 |
Why?
| | Staphylococcus aureus | 12 | 1999 | 459 | 0.350 |
Why?
| | Glycoproteins | 3 | 2011 | 356 | 0.340 |
Why?
| | Humans | 130 | 2025 | 146342 | 0.340 |
Why?
| | Cancer Vaccines | 5 | 2021 | 161 | 0.330 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 3 | 2018 | 64 | 0.330 |
Why?
| | Antigens, Bacterial | 8 | 2013 | 125 | 0.330 |
Why?
| | Clone Cells | 22 | 2024 | 259 | 0.320 |
Why?
| | Toll-Like Receptor 7 | 4 | 2016 | 43 | 0.320 |
Why?
| | Cells, Cultured | 36 | 2021 | 4118 | 0.320 |
Why?
| | Carrier Proteins | 10 | 2009 | 728 | 0.320 |
Why?
| | Interferon-gamma | 14 | 2016 | 781 | 0.320 |
Why?
| | B-Lymphocyte Subsets | 4 | 2020 | 78 | 0.310 |
Why?
| | Antibodies | 10 | 2009 | 400 | 0.310 |
Why?
| | Cell Differentiation | 28 | 2021 | 1982 | 0.290 |
Why?
| | Proinsulin | 2 | 2021 | 54 | 0.290 |
Why?
| | Ovalbumin | 21 | 2011 | 187 | 0.280 |
Why?
| | Signal Transduction | 17 | 2016 | 5246 | 0.280 |
Why?
| | CD11c Antigen | 5 | 2020 | 40 | 0.270 |
Why?
| | Nickel | 2 | 2012 | 63 | 0.270 |
Why?
| | Immunotherapy | 5 | 2021 | 671 | 0.270 |
Why?
| | Gene Expression | 11 | 2017 | 1463 | 0.270 |
Why?
| | Cross Reactions | 10 | 2012 | 130 | 0.270 |
Why?
| | Amino Acid Motifs | 7 | 2019 | 218 | 0.260 |
Why?
| | HLA-DQ Antigens | 6 | 2019 | 171 | 0.260 |
Why?
| | Immunoglobulin Fab Fragments | 3 | 2006 | 55 | 0.260 |
Why?
| | Cytokines | 13 | 2020 | 2081 | 0.260 |
Why?
| | beta 2-Microglobulin | 4 | 2010 | 47 | 0.250 |
Why?
| | Arthritis, Rheumatoid | 5 | 2014 | 1185 | 0.250 |
Why?
| | Cytochrome c Group | 5 | 2002 | 43 | 0.240 |
Why?
| | Insecta | 4 | 2009 | 73 | 0.240 |
Why?
| | Histones | 4 | 2018 | 670 | 0.230 |
Why?
| | Kinetics | 18 | 2021 | 1553 | 0.230 |
Why?
| | Dendritic Cells | 7 | 2013 | 509 | 0.230 |
Why?
| | Cell Proliferation | 10 | 2020 | 2502 | 0.230 |
Why?
| | HLA-D Antigens | 3 | 1998 | 30 | 0.220 |
Why?
| | Lupus Erythematosus, Systemic | 3 | 2017 | 241 | 0.220 |
Why?
| | Cell Survival | 18 | 2009 | 1105 | 0.220 |
Why?
| | Eicosapentaenoic Acid | 1 | 2025 | 37 | 0.220 |
Why?
| | Staphylococcus | 5 | 1994 | 74 | 0.220 |
Why?
| | Transcription, Genetic | 8 | 2020 | 1432 | 0.210 |
Why?
| | Docosahexaenoic Acids | 1 | 2025 | 91 | 0.210 |
Why?
| | Interleukin-12 | 2 | 2016 | 115 | 0.210 |
Why?
| | Protein Folding | 2 | 2021 | 281 | 0.210 |
Why?
| | Herpesviridae Infections | 2 | 2017 | 147 | 0.200 |
Why?
| | T-Lymphocytes, Helper-Inducer | 9 | 1989 | 127 | 0.200 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2025 | 145 | 0.200 |
Why?
| | Out-of-Hospital Cardiac Arrest | 1 | 2025 | 121 | 0.200 |
Why?
| | Macromolecular Substances | 17 | 2003 | 205 | 0.200 |
Why?
| | Surface Plasmon Resonance | 5 | 2021 | 87 | 0.190 |
Why?
| | Positive Transcriptional Elongation Factor B | 2 | 2020 | 28 | 0.190 |
Why?
| | DNA | 12 | 2016 | 1421 | 0.190 |
Why?
| | Macrophages | 19 | 2011 | 1532 | 0.190 |
Why?
| | T-Cell Antigen Receptor Specificity | 3 | 2011 | 45 | 0.190 |
Why?
| | Germ Cells | 2 | 2016 | 67 | 0.190 |
Why?
| | Mice, Knockout | 17 | 2024 | 3125 | 0.190 |
Why?
| | Concanavalin A | 18 | 1990 | 72 | 0.190 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 10 | 2017 | 846 | 0.190 |
Why?
| | Antiviral Agents | 2 | 2021 | 779 | 0.180 |
Why?
| | Receptors, Cell Surface | 3 | 2020 | 371 | 0.180 |
Why?
| | T-Box Domain Proteins | 4 | 2020 | 106 | 0.180 |
Why?
| | Natural Killer T-Cells | 2 | 2013 | 71 | 0.180 |
Why?
| | Cell Death | 13 | 2006 | 379 | 0.180 |
Why?
| | Lung | 7 | 2021 | 4122 | 0.180 |
Why?
| | Oligonucleotide Array Sequence Analysis | 5 | 2008 | 752 | 0.180 |
Why?
| | Neoplasms, Experimental | 3 | 2021 | 163 | 0.180 |
Why?
| | Polymorphism, Genetic | 6 | 2012 | 612 | 0.180 |
Why?
| | Vaccines, Subunit | 3 | 2012 | 53 | 0.180 |
Why?
| | Immune System | 5 | 2013 | 181 | 0.180 |
Why?
| | Transfection | 17 | 2009 | 916 | 0.180 |
Why?
| | Homeostasis | 5 | 2007 | 646 | 0.170 |
Why?
| | Sequence Homology, Amino Acid | 6 | 2019 | 382 | 0.170 |
Why?
| | Recombinant Proteins | 7 | 2005 | 1361 | 0.170 |
Why?
| | Structure-Activity Relationship | 10 | 2006 | 563 | 0.170 |
Why?
| | Crystallization | 2 | 2015 | 131 | 0.170 |
Why?
| | Peptidyl Transferases | 1 | 2021 | 8 | 0.170 |
Why?
| | Neoplasms | 5 | 2021 | 2954 | 0.170 |
Why?
| | Bcl-2-Like Protein 11 | 9 | 2009 | 37 | 0.170 |
Why?
| | Chemokine CCL4 | 1 | 2021 | 31 | 0.170 |
Why?
| | Chemokine CCL3 | 1 | 2021 | 26 | 0.170 |
Why?
| | Pancreas | 2 | 2021 | 343 | 0.170 |
Why?
| | Aging | 8 | 2015 | 1996 | 0.170 |
Why?
| | HLA-C Antigens | 1 | 2021 | 37 | 0.160 |
Why?
| | Saccharomyces cerevisiae | 1 | 2005 | 584 | 0.160 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 9 | 2011 | 326 | 0.160 |
Why?
| | Autoantibodies | 6 | 2017 | 1500 | 0.160 |
Why?
| | Cloning, Molecular | 12 | 2000 | 526 | 0.160 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2022 | 992 | 0.160 |
Why?
| | Female | 73 | 2025 | 79499 | 0.160 |
Why?
| | Epitope Mapping | 4 | 2015 | 61 | 0.160 |
Why?
| | Immunoglobulin Idiotypes | 6 | 1986 | 28 | 0.160 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2020 | 17 | 0.160 |
Why?
| | Synovial Fluid | 2 | 2000 | 69 | 0.160 |
Why?
| | HLA-DP Antigens | 2 | 2010 | 32 | 0.160 |
Why?
| | RNA Polymerase II | 2 | 2020 | 347 | 0.150 |
Why?
| | Hemolytic Plaque Technique | 16 | 1983 | 28 | 0.150 |
Why?
| | Substrate Specificity | 3 | 2017 | 389 | 0.150 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2020 | 642 | 0.150 |
Why?
| | Glycosaminoglycans | 1 | 2000 | 79 | 0.150 |
Why?
| | Animal Fur | 1 | 2019 | 1 | 0.150 |
Why?
| | Genes | 15 | 1990 | 215 | 0.150 |
Why?
| | Nerve Growth Factors | 1 | 2000 | 79 | 0.150 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 250 | 0.150 |
Why?
| | CD8 Antigens | 9 | 2006 | 70 | 0.150 |
Why?
| | Haptens | 4 | 1988 | 25 | 0.150 |
Why?
| | Inflammation | 5 | 2020 | 2919 | 0.150 |
Why?
| | Cell Separation | 13 | 2014 | 300 | 0.150 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2020 | 96 | 0.150 |
Why?
| | Minor Lymphocyte Stimulatory Antigens | 11 | 1993 | 22 | 0.150 |
Why?
| | Membrane Glycoproteins | 6 | 2013 | 495 | 0.150 |
Why?
| | Lipocalins | 1 | 2019 | 35 | 0.150 |
Why?
| | DNA Mutational Analysis | 2 | 2009 | 410 | 0.150 |
Why?
| | Methyltransferases | 1 | 2020 | 74 | 0.150 |
Why?
| | Cell Line, Transformed | 2 | 2018 | 137 | 0.150 |
Why?
| | Vaccines | 3 | 2016 | 389 | 0.150 |
Why?
| | Mice, Inbred DBA | 20 | 2002 | 186 | 0.150 |
Why?
| | Sarcoidosis, Pulmonary | 1 | 2020 | 100 | 0.140 |
Why?
| | Interleukin-4 | 6 | 2008 | 207 | 0.140 |
Why?
| | Lymph Nodes | 12 | 2013 | 511 | 0.140 |
Why?
| | HIV Envelope Protein gp120 | 1 | 1999 | 55 | 0.140 |
Why?
| | Protein Structure, Secondary | 5 | 2012 | 357 | 0.140 |
Why?
| | Molecular Weight | 12 | 2006 | 295 | 0.140 |
Why?
| | Genetic Linkage | 8 | 2002 | 271 | 0.140 |
Why?
| | Cell Division | 12 | 2008 | 736 | 0.140 |
Why?
| | Disease Models, Animal | 7 | 2015 | 4580 | 0.140 |
Why?
| | Mice, Mutant Strains | 8 | 2014 | 290 | 0.140 |
Why?
| | Antibody Specificity | 11 | 2020 | 181 | 0.140 |
Why?
| | Species Specificity | 12 | 2006 | 543 | 0.140 |
Why?
| | T-Lymphocytes, Regulatory | 4 | 2014 | 415 | 0.140 |
Why?
| | Th2 Cells | 3 | 2010 | 179 | 0.140 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 269 | 0.140 |
Why?
| | Genome | 2 | 2000 | 307 | 0.130 |
Why?
| | Hybrid Cells | 4 | 1997 | 47 | 0.130 |
Why?
| | Antigens, Ly | 4 | 1988 | 46 | 0.130 |
Why?
| | Transcription Factors | 5 | 2024 | 1730 | 0.130 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 103 | 0.130 |
Why?
| | Gene Expression Profiling | 5 | 2013 | 1792 | 0.130 |
Why?
| | bcl-X Protein | 4 | 2006 | 44 | 0.130 |
Why?
| | Hemocyanins | 9 | 1983 | 61 | 0.130 |
Why?
| | Cell Line, Tumor | 6 | 2021 | 3545 | 0.130 |
Why?
| | Vaccination | 8 | 2010 | 1449 | 0.130 |
Why?
| | Herpesviridae | 1 | 2017 | 21 | 0.130 |
Why?
| | Interleukin-7 | 4 | 2004 | 66 | 0.130 |
Why?
| | Cat Diseases | 1 | 2017 | 37 | 0.120 |
Why?
| | Fluorescent Antibody Technique | 6 | 2011 | 345 | 0.120 |
Why?
| | Spodoptera | 3 | 2021 | 39 | 0.120 |
Why?
| | Erythrocytes | 25 | 2002 | 750 | 0.120 |
Why?
| | Solubility | 5 | 2003 | 240 | 0.120 |
Why?
| | Friend murine leukemia virus | 1 | 2016 | 31 | 0.120 |
Why?
| | Deoxyribonucleases | 1 | 2016 | 24 | 0.120 |
Why?
| | Cell Communication | 8 | 2013 | 327 | 0.120 |
Why?
| | Antibody-Producing Cells | 11 | 1983 | 30 | 0.120 |
Why?
| | Allergens | 1 | 2019 | 390 | 0.120 |
Why?
| | Germ-Line Mutation | 2 | 2009 | 180 | 0.120 |
Why?
| | Antibody Affinity | 4 | 2020 | 60 | 0.120 |
Why?
| | Immunity | 3 | 2007 | 141 | 0.120 |
Why?
| | Mice, Inbred AKR | 10 | 1989 | 35 | 0.120 |
Why?
| | Thymocytes | 2 | 2013 | 33 | 0.120 |
Why?
| | Protein Precursors | 1 | 2016 | 127 | 0.120 |
Why?
| | Immunologic Deficiency Syndromes | 3 | 2007 | 69 | 0.120 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2008 | 198 | 0.120 |
Why?
| | Binding, Competitive | 9 | 2010 | 185 | 0.120 |
Why?
| | Clonal Anergy | 3 | 2006 | 55 | 0.120 |
Why?
| | Methylation | 5 | 2018 | 241 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 6 | 2021 | 2488 | 0.110 |
Why?
| | Mast Cells | 2 | 2009 | 150 | 0.110 |
Why?
| | Cytotoxicity, Immunologic | 8 | 2010 | 224 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 3 | 1988 | 432 | 0.110 |
Why?
| | History, 20th Century | 4 | 2016 | 330 | 0.110 |
Why?
| | Influenza A virus | 2 | 2013 | 120 | 0.110 |
Why?
| | Cerebroside-Sulfatase | 2 | 1993 | 3 | 0.110 |
Why?
| | Leukodystrophy, Metachromatic | 2 | 1993 | 4 | 0.110 |
Why?
| | Reactive Oxygen Species | 3 | 2003 | 610 | 0.110 |
Why?
| | Polymerase Chain Reaction | 7 | 2016 | 1031 | 0.110 |
Why?
| | RNA, Messenger | 11 | 2022 | 2791 | 0.110 |
Why?
| | Tumor Necrosis Factor-alpha | 6 | 2006 | 1224 | 0.110 |
Why?
| | Self Tolerance | 2 | 1996 | 27 | 0.110 |
Why?
| | T-Lymphocytes, Cytotoxic | 4 | 2011 | 180 | 0.110 |
Why?
| | Interleukin-15 | 5 | 2006 | 96 | 0.100 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 348 | 0.100 |
Why?
| | Peptide Biosynthesis | 1 | 1994 | 13 | 0.100 |
Why?
| | Mutagenesis, Site-Directed | 3 | 2011 | 371 | 0.100 |
Why?
| | Receptors, Immunologic | 3 | 2020 | 210 | 0.100 |
Why?
| | Ribosomal Proteins | 1 | 2014 | 93 | 0.100 |
Why?
| | Breast Neoplasms | 2 | 2018 | 2418 | 0.100 |
Why?
| | Cysteine | 2 | 2010 | 210 | 0.100 |
Why?
| | Mutagenesis | 3 | 2021 | 196 | 0.100 |
Why?
| | Granuloma | 1 | 2014 | 96 | 0.100 |
Why?
| | gamma-Globulins | 4 | 1983 | 14 | 0.100 |
Why?
| | Haplotypes | 4 | 1990 | 506 | 0.100 |
Why?
| | Immunity, Innate | 4 | 2021 | 844 | 0.100 |
Why?
| | Clonal Deletion | 4 | 2004 | 16 | 0.100 |
Why?
| | Sodium | 1 | 2014 | 196 | 0.100 |
Why?
| | Hydrogen Bonding | 2 | 2008 | 170 | 0.100 |
Why?
| | Antigens, CD | 5 | 2001 | 560 | 0.100 |
Why?
| | Gammaherpesvirinae | 1 | 2013 | 45 | 0.100 |
Why?
| | Nucleoproteins | 1 | 2013 | 37 | 0.100 |
Why?
| | Viral Proteins | 2 | 2009 | 351 | 0.100 |
Why?
| | Chimera | 8 | 2009 | 62 | 0.090 |
Why?
| | Antigen-Antibody Reactions | 7 | 2021 | 50 | 0.090 |
Why?
| | HLA Antigens | 4 | 2018 | 241 | 0.090 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 82 | 0.090 |
Why?
| | Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2012 | 31 | 0.090 |
Why?
| | CD4 Antigens | 9 | 1998 | 136 | 0.090 |
Why?
| | Genes, Immunoglobulin | 3 | 1988 | 29 | 0.090 |
Why?
| | Lymphocyte Depletion | 5 | 2001 | 135 | 0.090 |
Why?
| | Diabetes Mellitus | 1 | 2021 | 1101 | 0.090 |
Why?
| | Multiprotein Complexes | 1 | 2014 | 168 | 0.090 |
Why?
| | Escherichia coli | 4 | 2013 | 832 | 0.090 |
Why?
| | Models, Immunological | 4 | 2008 | 100 | 0.090 |
Why?
| | Chromosome Mapping | 8 | 2002 | 508 | 0.090 |
Why?
| | B7-1 Antigen | 3 | 2004 | 55 | 0.090 |
Why?
| | Antigens, Differentiation, B-Lymphocyte | 3 | 2013 | 36 | 0.090 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2012 | 131 | 0.090 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2012 | 74 | 0.090 |
Why?
| | Dose-Response Relationship, Immunologic | 12 | 2000 | 77 | 0.090 |
Why?
| | Amino Acid Substitution | 3 | 2021 | 297 | 0.090 |
Why?
| | Communicable Diseases | 1 | 1994 | 166 | 0.090 |
Why?
| | Phagocytosis | 2 | 2011 | 298 | 0.080 |
Why?
| | Intestinal Mucosa | 1 | 1997 | 666 | 0.080 |
Why?
| | Sheep | 20 | 1983 | 870 | 0.080 |
Why?
| | Antilymphocyte Serum | 9 | 1981 | 55 | 0.080 |
Why?
| | Lipid A | 1 | 2011 | 27 | 0.080 |
Why?
| | Receptors, CXCR5 | 1 | 2011 | 29 | 0.080 |
Why?
| | Molecular Conformation | 2 | 2009 | 141 | 0.080 |
Why?
| | Glycosylation | 4 | 1994 | 177 | 0.080 |
Why?
| | Th1 Cells | 2 | 2010 | 139 | 0.080 |
Why?
| | Immunization | 8 | 2004 | 376 | 0.080 |
Why?
| | Trypsin | 5 | 2006 | 73 | 0.080 |
Why?
| | Aluminum | 1 | 2010 | 43 | 0.080 |
Why?
| | Male | 30 | 2025 | 73396 | 0.080 |
Why?
| | Neoplasm Proteins | 1 | 2013 | 444 | 0.080 |
Why?
| | Gene Deletion | 2 | 2009 | 385 | 0.080 |
Why?
| | Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2010 | 8 | 0.080 |
Why?
| | Crosses, Genetic | 7 | 2006 | 120 | 0.080 |
Why?
| | DNA, Recombinant | 4 | 2005 | 46 | 0.080 |
Why?
| | Lymphocyte Count | 4 | 2010 | 167 | 0.080 |
Why?
| | Complement C3 | 1 | 2011 | 195 | 0.080 |
Why?
| | Insulin-Secreting Cells | 2 | 2016 | 393 | 0.080 |
Why?
| | Epstein-Barr Virus Nuclear Antigens | 1 | 2009 | 12 | 0.080 |
Why?
| | DNA-Binding Proteins | 3 | 2014 | 1468 | 0.080 |
Why?
| | In Vitro Techniques | 8 | 2000 | 1041 | 0.080 |
Why?
| | Chickens | 9 | 1994 | 169 | 0.080 |
Why?
| | Molecular Mimicry | 1 | 2009 | 36 | 0.080 |
Why?
| | Radiation Chimera | 6 | 2001 | 28 | 0.080 |
Why?
| | Leukemia, Lymphoid | 3 | 2006 | 27 | 0.080 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 2 | 2006 | 14 | 0.080 |
Why?
| | Chronic Disease | 5 | 2021 | 1827 | 0.070 |
Why?
| | Molecular Docking Simulation | 2 | 2021 | 121 | 0.070 |
Why?
| | HLA-B Antigens | 1 | 2009 | 59 | 0.070 |
Why?
| | Chromosomes, Human, X | 1 | 2010 | 76 | 0.070 |
Why?
| | Histidine | 2 | 2003 | 67 | 0.070 |
Why?
| | Immunoglobulin Heavy Chains | 6 | 1988 | 83 | 0.070 |
Why?
| | Cell Membrane | 6 | 2004 | 701 | 0.070 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 89 | 0.070 |
Why?
| | Mice, Inbred C3H | 7 | 1993 | 252 | 0.070 |
Why?
| | Receptors, Interleukin-2 | 4 | 2003 | 64 | 0.070 |
Why?
| | Sequence Alignment | 2 | 2008 | 360 | 0.070 |
Why?
| | RNA | 4 | 2010 | 926 | 0.070 |
Why?
| | Time Factors | 12 | 2013 | 7109 | 0.070 |
Why?
| | Immunity, Humoral | 2 | 2022 | 121 | 0.070 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2003 | 534 | 0.070 |
Why?
| | Oligopeptides | 2 | 2001 | 264 | 0.070 |
Why?
| | Fluorescent Dyes | 2 | 2001 | 340 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2008 | 14 | 0.070 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 525 | 0.070 |
Why?
| | Gonadal Steroid Hormones | 1 | 2010 | 143 | 0.070 |
Why?
| | Lymphocytes | 6 | 1997 | 379 | 0.070 |
Why?
| | Mass Spectrometry | 3 | 2020 | 729 | 0.070 |
Why?
| | Chondroitin | 1 | 1988 | 6 | 0.070 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 1988 | 38 | 0.070 |
Why?
| | Ubiquitination | 1 | 2008 | 119 | 0.070 |
Why?
| | Mice, Inbred CBA | 8 | 2001 | 56 | 0.070 |
Why?
| | Receptors, Tumor Necrosis Factor | 3 | 2003 | 162 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2008 | 47 | 0.070 |
Why?
| | Interleukin-6 | 3 | 2011 | 784 | 0.070 |
Why?
| | Chondroitin Sulfates | 1 | 1988 | 35 | 0.070 |
Why?
| | Herpesvirus 4, Human | 1 | 2009 | 172 | 0.070 |
Why?
| | Protein Domains | 2 | 2020 | 315 | 0.070 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 106 | 0.070 |
Why?
| | Interferon-beta | 2 | 2006 | 90 | 0.070 |
Why?
| | Cell Movement | 5 | 2013 | 951 | 0.070 |
Why?
| | Galactosylceramides | 1 | 2007 | 28 | 0.070 |
Why?
| | Heterozygote | 2 | 2024 | 311 | 0.070 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 2007 | 17 | 0.060 |
Why?
| | Blotting, Western | 3 | 2020 | 1177 | 0.060 |
Why?
| | Antigens, CD1d | 3 | 2013 | 69 | 0.060 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 2 | 2001 | 15 | 0.060 |
Why?
| | Phenotype | 10 | 2008 | 3206 | 0.060 |
Why?
| | Interferon-alpha | 2 | 2006 | 201 | 0.060 |
Why?
| | Recombinant Fusion Proteins | 5 | 2002 | 663 | 0.060 |
Why?
| | Open Reading Frames | 3 | 1992 | 130 | 0.060 |
Why?
| | Bone Marrow Cells | 3 | 2016 | 328 | 0.060 |
Why?
| | Sequence Homology, Nucleic Acid | 7 | 1992 | 157 | 0.060 |
Why?
| | Killer Cells, Natural | 2 | 2007 | 481 | 0.060 |
Why?
| | Molecular Structure | 2 | 2003 | 484 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2009 | 508 | 0.060 |
Why?
| | Poly I-C | 1 | 2006 | 58 | 0.060 |
Why?
| | Restriction Mapping | 3 | 1998 | 80 | 0.060 |
Why?
| | Arginine | 2 | 2018 | 264 | 0.060 |
Why?
| | Chemotaxis, Leukocyte | 2 | 2003 | 115 | 0.060 |
Why?
| | Cell Culture Techniques | 3 | 2009 | 371 | 0.060 |
Why?
| | Protein Biosynthesis | 3 | 1992 | 449 | 0.060 |
Why?
| | Moths | 3 | 1997 | 45 | 0.060 |
Why?
| | Proteins | 2 | 1982 | 1022 | 0.060 |
Why?
| | Jurkat Cells | 2 | 2009 | 115 | 0.060 |
Why?
| | Hyaluronan Receptors | 3 | 2003 | 105 | 0.060 |
Why?
| | Promoter Regions, Genetic | 4 | 2020 | 1242 | 0.060 |
Why?
| | Bone Marrow | 4 | 2009 | 310 | 0.060 |
Why?
| | Epithelium | 6 | 1997 | 295 | 0.060 |
Why?
| | Nitrophenols | 10 | 2004 | 30 | 0.060 |
Why?
| | Lipopolysaccharides | 8 | 2002 | 861 | 0.050 |
Why?
| | Proteolysis | 2 | 2018 | 174 | 0.050 |
Why?
| | Organ Culture Techniques | 6 | 1993 | 150 | 0.050 |
Why?
| | Oligonucleotides | 2 | 2004 | 155 | 0.050 |
Why?
| | Exons | 2 | 2000 | 361 | 0.050 |
Why?
| | Histiocytosis, Non-Langerhans-Cell | 1 | 2004 | 5 | 0.050 |
Why?
| | CD4-CD8 Ratio | 2 | 2002 | 23 | 0.050 |
Why?
| | Mice, Inbred A | 6 | 1984 | 47 | 0.050 |
Why?
| | Histocompatibility Antigen H-2D | 4 | 2010 | 20 | 0.050 |
Why?
| | Case-Control Studies | 3 | 2020 | 3647 | 0.050 |
Why?
| | Phosphorylation | 4 | 2020 | 1724 | 0.050 |
Why?
| | Receptors, Leukotriene B4 | 1 | 2003 | 7 | 0.050 |
Why?
| | Microtubule-Associated Proteins | 1 | 2005 | 187 | 0.050 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2004 | 132 | 0.050 |
Why?
| | Gene Library | 1 | 2004 | 121 | 0.050 |
Why?
| | Leukotriene B4 | 1 | 2003 | 37 | 0.050 |
Why?
| | CD28 Antigens | 2 | 2008 | 57 | 0.050 |
Why?
| | Luminescent Proteins | 2 | 2001 | 188 | 0.050 |
Why?
| | Myeloid Cells | 1 | 2004 | 149 | 0.050 |
Why?
| | Genes, bcl-2 | 1 | 2002 | 21 | 0.050 |
Why?
| | Selection, Genetic | 2 | 2019 | 269 | 0.050 |
Why?
| | Immunoblotting | 3 | 2008 | 294 | 0.050 |
Why?
| | NF-kappa B | 2 | 2004 | 674 | 0.050 |
Why?
| | Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2002 | 9 | 0.050 |
Why?
| | Chemokine CCL5 | 1 | 2002 | 40 | 0.050 |
Why?
| | Talin | 1 | 2002 | 9 | 0.050 |
Why?
| | Phosphoproteins | 1 | 2005 | 320 | 0.050 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2002 | 16 | 0.050 |
Why?
| | Clodronic Acid | 1 | 2002 | 19 | 0.050 |
Why?
| | Anemia, Hemolytic, Autoimmune | 1 | 2002 | 17 | 0.050 |
Why?
| | Serum Albumin, Bovine | 6 | 2011 | 63 | 0.050 |
Why?
| | Leukocyte Common Antigens | 1 | 2002 | 86 | 0.050 |
Why?
| | Cell Fusion | 4 | 1989 | 47 | 0.050 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2002 | 429 | 0.040 |
Why?
| | Vaccines, Synthetic | 1 | 2022 | 138 | 0.040 |
Why?
| | DNA, Viral | 1 | 2004 | 354 | 0.040 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2002 | 92 | 0.040 |
Why?
| | Egg Proteins | 1 | 2001 | 14 | 0.040 |
Why?
| | Genetic Vectors | 2 | 2001 | 327 | 0.040 |
Why?
| | Moloney murine leukemia virus | 1 | 2001 | 12 | 0.040 |
Why?
| | Colorectal Neoplasms | 1 | 2010 | 874 | 0.040 |
Why?
| | Sf9 Cells | 1 | 2021 | 11 | 0.040 |
Why?
| | Genotype | 4 | 2015 | 1879 | 0.040 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2025 | 334 | 0.040 |
Why?
| | CD40 Antigens | 1 | 2001 | 69 | 0.040 |
Why?
| | Sequence Analysis, DNA | 1 | 2004 | 771 | 0.040 |
Why?
| | Transduction, Genetic | 1 | 2001 | 129 | 0.040 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 1992 | 116 | 0.040 |
Why?
| | Temperature | 2 | 2003 | 635 | 0.040 |
Why?
| | Interleukin-1 | 5 | 1997 | 960 | 0.040 |
Why?
| | Dimerization | 2 | 2001 | 174 | 0.040 |
Why?
| | Adoptive Transfer | 4 | 2004 | 197 | 0.040 |
Why?
| | Receptors, Fc | 2 | 2020 | 54 | 0.040 |
Why?
| | Allergy and Immunology | 1 | 2001 | 42 | 0.040 |
Why?
| | Borrelia burgdorferi Group | 1 | 2000 | 7 | 0.040 |
Why?
| | Melanoma, Experimental | 1 | 2001 | 106 | 0.040 |
Why?
| | Calcium | 6 | 2004 | 1181 | 0.040 |
Why?
| | HIV Infections | 1 | 2016 | 3215 | 0.040 |
Why?
| | Perissodactyla | 8 | 1981 | 13 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2004 | 429 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2005 | 630 | 0.040 |
Why?
| | Models, Animal | 1 | 2002 | 387 | 0.040 |
Why?
| | Immunoglobulin E | 2 | 2019 | 315 | 0.040 |
Why?
| | Receptors, Virus | 1 | 2021 | 91 | 0.040 |
Why?
| | Netrin-1 | 1 | 2000 | 17 | 0.040 |
Why?
| | Phorbol Esters | 1 | 2000 | 13 | 0.040 |
Why?
| | Biotinylation | 1 | 2000 | 37 | 0.040 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2001 | 134 | 0.040 |
Why?
| | Expressed Sequence Tags | 1 | 2000 | 43 | 0.040 |
Why?
| | Green Fluorescent Proteins | 3 | 2013 | 408 | 0.040 |
Why?
| | Middle Aged | 6 | 2025 | 36619 | 0.040 |
Why?
| | Survival Rate | 1 | 2025 | 2092 | 0.040 |
Why?
| | Glucose Intolerance | 1 | 2021 | 142 | 0.040 |
Why?
| | Immune Sera | 5 | 1984 | 77 | 0.040 |
Why?
| | Calorimetry | 1 | 2000 | 69 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2021 | 145 | 0.040 |
Why?
| | Haploidy | 1 | 1980 | 30 | 0.040 |
Why?
| | GTP Phosphohydrolases | 1 | 2000 | 95 | 0.040 |
Why?
| | Circular Dichroism | 1 | 2000 | 149 | 0.040 |
Why?
| | B-Cell Activating Factor | 3 | 2006 | 21 | 0.040 |
Why?
| | Cytoskeletal Proteins | 1 | 2000 | 146 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2021 | 267 | 0.040 |
Why?
| | Transcription Factor AP-1 | 1 | 2000 | 76 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2019 | 18 | 0.040 |
Why?
| | Hot Temperature | 2 | 2000 | 396 | 0.040 |
Why?
| | Homozygote | 2 | 1991 | 197 | 0.040 |
Why?
| | Lymphocytic choriomeningitis virus | 2 | 2011 | 36 | 0.040 |
Why?
| | Mitochondria | 2 | 2004 | 997 | 0.040 |
Why?
| | Receptors, Complement 3d | 1 | 2020 | 150 | 0.040 |
Why?
| | Biological Transport | 2 | 1999 | 424 | 0.040 |
Why?
| | Aged | 4 | 2025 | 26432 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 122 | 0.040 |
Why?
| | Retroviridae | 2 | 2013 | 99 | 0.040 |
Why?
| | Lipoproteins | 1 | 2000 | 165 | 0.040 |
Why?
| | Mice, Nude | 3 | 2013 | 668 | 0.040 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 1999 | 70 | 0.040 |
Why?
| | Vaccinia | 1 | 1999 | 20 | 0.040 |
Why?
| | Immunization, Secondary | 1 | 1999 | 94 | 0.040 |
Why?
| | Plasmids | 4 | 2001 | 373 | 0.040 |
Why?
| | Binding Sites, Antibody | 6 | 1991 | 41 | 0.040 |
Why?
| | fas Receptor | 4 | 2002 | 91 | 0.040 |
Why?
| | Computer Simulation | 1 | 2003 | 1014 | 0.040 |
Why?
| | Rabbits | 6 | 1984 | 651 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 441 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 974 | 0.040 |
Why?
| | Trans-Activators | 2 | 2000 | 372 | 0.040 |
Why?
| | Trinitrobenzenes | 5 | 1982 | 14 | 0.040 |
Why?
| | Recombination, Genetic | 4 | 1988 | 202 | 0.040 |
Why?
| | Fibroblasts | 4 | 2017 | 1034 | 0.030 |
Why?
| | Horses | 8 | 1981 | 229 | 0.030 |
Why?
| | Cell Cycle | 2 | 2020 | 595 | 0.030 |
Why?
| | Precipitin Tests | 3 | 2001 | 90 | 0.030 |
Why?
| | Heparin | 1 | 2000 | 247 | 0.030 |
Why?
| | Coculture Techniques | 2 | 2013 | 245 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2013 | 372 | 0.030 |
Why?
| | Nucleosomes | 1 | 2020 | 168 | 0.030 |
Why?
| | Cartilage | 1 | 2000 | 198 | 0.030 |
Why?
| | Asparagine | 1 | 1998 | 34 | 0.030 |
Why?
| | DNA Repair | 1 | 2020 | 255 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2000 | 253 | 0.030 |
Why?
| | Crystallography | 2 | 2007 | 26 | 0.030 |
Why?
| | Hemoglobins | 2 | 2001 | 384 | 0.030 |
Why?
| | Dogs | 1 | 2019 | 517 | 0.030 |
Why?
| | Interferon Type I | 1 | 1999 | 147 | 0.030 |
Why?
| | Codon | 1 | 1998 | 92 | 0.030 |
Why?
| | Tumor Suppressor Proteins | 1 | 2000 | 315 | 0.030 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 1978 | 41 | 0.030 |
Why?
| | Receptors, Interferon | 2 | 2013 | 60 | 0.030 |
Why?
| | Caspases | 2 | 2014 | 233 | 0.030 |
Why?
| | Lupus Nephritis | 2 | 2006 | 67 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 1999 | 307 | 0.030 |
Why?
| | Cricetinae | 3 | 1994 | 296 | 0.030 |
Why?
| | Immunoprecipitation | 2 | 2008 | 150 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 366 | 0.030 |
Why?
| | Immunoglobulin Constant Regions | 3 | 1986 | 7 | 0.030 |
Why?
| | Collagen | 1 | 2000 | 460 | 0.030 |
Why?
| | Age Factors | 4 | 2017 | 3347 | 0.030 |
Why?
| | Phylogeny | 1 | 2021 | 924 | 0.030 |
Why?
| | Receptors, IgE | 1 | 1997 | 43 | 0.030 |
Why?
| | Epithelial Cells | 2 | 2021 | 1119 | 0.030 |
Why?
| | Societies, Medical | 1 | 2001 | 907 | 0.030 |
Why?
| | Virus Diseases | 2 | 1992 | 219 | 0.030 |
Why?
| | Cats | 1 | 2017 | 226 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2000 | 430 | 0.030 |
Why?
| | Respiratory Hypersensitivity | 1 | 1997 | 65 | 0.030 |
Why?
| | Germinal Center | 1 | 2017 | 67 | 0.030 |
Why?
| | Columbidae | 2 | 1994 | 31 | 0.030 |
Why?
| | Chromatography, Gel | 3 | 2014 | 131 | 0.030 |
Why?
| | Young Adult | 3 | 2020 | 14330 | 0.030 |
Why?
| | Emulsions | 1 | 2016 | 58 | 0.030 |
Why?
| | Drug Contamination | 1 | 2016 | 56 | 0.030 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 1996 | 76 | 0.030 |
Why?
| | High-Throughput Screening Assays | 1 | 2018 | 179 | 0.030 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2016 | 119 | 0.030 |
Why?
| | Fetus | 3 | 1993 | 800 | 0.030 |
Why?
| | Hematopoiesis | 1 | 1997 | 195 | 0.030 |
Why?
| | C-Peptide | 1 | 2016 | 191 | 0.030 |
Why?
| | Down-Regulation | 3 | 2003 | 614 | 0.030 |
Why?
| | Chemokine CCL19 | 1 | 2015 | 5 | 0.030 |
Why?
| | Chemokine CCL21 | 1 | 2015 | 13 | 0.030 |
Why?
| | Immunoconjugates | 1 | 1997 | 138 | 0.030 |
Why?
| | Immunoglobulin Isotypes | 2 | 2008 | 36 | 0.030 |
Why?
| | Receptors, CCR7 | 1 | 2015 | 32 | 0.030 |
Why?
| | Imidazoles | 1 | 2016 | 245 | 0.030 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2012 | 21 | 0.030 |
Why?
| | Tumor Cells, Cultured | 4 | 2001 | 882 | 0.030 |
Why?
| | Static Electricity | 1 | 2015 | 113 | 0.030 |
Why?
| | Genes, T-Cell Receptor beta | 1 | 2014 | 22 | 0.030 |
Why?
| | Antibody Diversity | 3 | 1989 | 16 | 0.030 |
Why?
| | Adult | 6 | 2020 | 41087 | 0.030 |
Why?
| | Immunophenotyping | 3 | 2004 | 324 | 0.030 |
Why?
| | V(D)J Recombination | 1 | 2014 | 8 | 0.030 |
Why?
| | Cattle | 4 | 2011 | 940 | 0.030 |
Why?
| | Enzyme-Linked Immunospot Assay | 1 | 2014 | 40 | 0.030 |
Why?
| | Biological Transport, Active | 1 | 1994 | 69 | 0.030 |
Why?
| | Enzyme Activation | 3 | 2001 | 759 | 0.030 |
Why?
| | Glutamic Acid | 2 | 2010 | 255 | 0.030 |
Why?
| | Databases, Factual | 1 | 2000 | 1493 | 0.030 |
Why?
| | Culture Techniques | 2 | 1973 | 65 | 0.030 |
Why?
| | Early Growth Response Protein 2 | 1 | 2013 | 10 | 0.030 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 5 | 1999 | 26 | 0.030 |
Why?
| | Chromatography, Ion Exchange | 1 | 2014 | 57 | 0.030 |
Why?
| | Endopeptidases | 1 | 1994 | 80 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 1994 | 99 | 0.020 |
Why?
| | Receptors, Interleukin-7 | 2 | 2006 | 28 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2003 | 2022 | 0.020 |
Why?
| | Genetic Carrier Screening | 1 | 1993 | 31 | 0.020 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2013 | 16 | 0.020 |
Why?
| | Thymectomy | 5 | 1975 | 15 | 0.020 |
Why?
| | Endopeptidase K | 1 | 2013 | 17 | 0.020 |
Why?
| | Viral Envelope Proteins | 1 | 1994 | 97 | 0.020 |
Why?
| | Growth Substances | 2 | 1983 | 136 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2014 | 209 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2015 | 310 | 0.020 |
Why?
| | HLA-DR Serological Subtypes | 1 | 2012 | 4 | 0.020 |
Why?
| | Kidney | 2 | 2017 | 1498 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 426 | 0.020 |
Why?
| | Diphtheria Toxin | 1 | 2013 | 61 | 0.020 |
Why?
| | Adaptive Immunity | 1 | 2014 | 173 | 0.020 |
Why?
| | Antibodies, Viral | 1 | 2017 | 689 | 0.020 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2013 | 47 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2025 | 11821 | 0.020 |
Why?
| | Vomiting | 1 | 1993 | 131 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 334 | 0.020 |
Why?
| | Prospective Studies | 1 | 2025 | 8123 | 0.020 |
Why?
| | Genes, MHC Class I | 2 | 2009 | 37 | 0.020 |
Why?
| | Dinoprostone | 2 | 1991 | 179 | 0.020 |
Why?
| | DNA Primers | 1 | 2013 | 487 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 712 | 0.020 |
Why?
| | Microsomes | 1 | 1992 | 33 | 0.020 |
Why?
| | DNA Restriction Enzymes | 3 | 1986 | 46 | 0.020 |
Why?
| | Zinc | 1 | 1995 | 310 | 0.020 |
Why?
| | Phosphotyrosine | 2 | 2002 | 38 | 0.020 |
Why?
| | Immunoassay | 2 | 1989 | 108 | 0.020 |
Why?
| | Adolescent | 4 | 2016 | 22557 | 0.020 |
Why?
| | Vinblastine | 3 | 1976 | 75 | 0.020 |
Why?
| | Vaccinia virus | 2 | 2001 | 35 | 0.020 |
Why?
| | Nucleocapsid Proteins | 1 | 2011 | 28 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2014 | 1298 | 0.020 |
Why?
| | Viral Core Proteins | 1 | 2011 | 21 | 0.020 |
Why?
| | Child | 4 | 2016 | 22693 | 0.020 |
Why?
| | Methionine | 1 | 1992 | 160 | 0.020 |
Why?
| | Resting Phase, Cell Cycle | 1 | 2011 | 16 | 0.020 |
Why?
| | Receptors, Lymphocyte Homing | 1 | 2011 | 15 | 0.020 |
Why?
| | Mice, Inbred NZB | 2 | 2007 | 16 | 0.020 |
Why?
| | Cell Adhesion | 3 | 1999 | 447 | 0.020 |
Why?
| | Carbohydrates | 1 | 1991 | 66 | 0.020 |
Why?
| | Rats | 5 | 2000 | 5586 | 0.020 |
Why?
| | Rosette Formation | 2 | 1980 | 14 | 0.020 |
Why?
| | Salts | 1 | 2010 | 34 | 0.020 |
Why?
| | Bone Marrow Transplantation | 2 | 1992 | 301 | 0.020 |
Why?
| | Proteomics | 1 | 2018 | 1203 | 0.020 |
Why?
| | Minor Histocompatibility Loci | 1 | 1990 | 3 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 1992 | 319 | 0.020 |
Why?
| | Mutant Chimeric Proteins | 1 | 2010 | 5 | 0.020 |
Why?
| | Orthomyxoviridae Infections | 1 | 2011 | 72 | 0.020 |
Why?
| | Cellular Senescence | 1 | 1993 | 225 | 0.020 |
Why?
| | Milk | 1 | 1991 | 117 | 0.020 |
Why?
| | Depression, Chemical | 1 | 1990 | 16 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2010 | 90 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 2010 | 58 | 0.020 |
Why?
| | Lysine | 1 | 2012 | 303 | 0.020 |
Why?
| | Epoprostenol | 1 | 1991 | 132 | 0.020 |
Why?
| | HLA-B8 Antigen | 1 | 2009 | 11 | 0.020 |
Why?
| | Immunodominant Epitopes | 1 | 2010 | 27 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 52 | 0.020 |
Why?
| | Fibrin | 1 | 2010 | 84 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 1993 | 288 | 0.020 |
Why?
| | Colonic Neoplasms | 1 | 2012 | 259 | 0.020 |
Why?
| | Injections, Intraperitoneal | 1 | 2009 | 115 | 0.020 |
Why?
| | Antioxidants | 2 | 2003 | 544 | 0.020 |
Why?
| | Thrombin | 1 | 2010 | 175 | 0.020 |
Why?
| | Chromosome Deletion | 4 | 1991 | 127 | 0.020 |
Why?
| | Fibrinogen | 1 | 2010 | 182 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2010 | 119 | 0.020 |
Why?
| | Immunoglobulin Class Switching | 1 | 2009 | 21 | 0.020 |
Why?
| | Immunoglobulin Joining Region | 1 | 1988 | 10 | 0.020 |
Why?
| | Deoxyribonuclease HpaII | 1 | 1988 | 2 | 0.020 |
Why?
| | Deoxyribonuclease BamHI | 1 | 1988 | 3 | 0.020 |
Why?
| | Disulfides | 3 | 2003 | 93 | 0.020 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 14 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2013 | 533 | 0.020 |
Why?
| | Caspase 1 | 1 | 2009 | 145 | 0.020 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2011 | 268 | 0.020 |
Why?
| | Goats | 3 | 1973 | 18 | 0.020 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 1 | 2008 | 15 | 0.020 |
Why?
| | Phosphorylcholine | 1 | 1988 | 19 | 0.020 |
Why?
| | Integrin alpha4 | 1 | 2008 | 7 | 0.020 |
Why?
| | Cell Adhesion Molecules | 1 | 1990 | 180 | 0.020 |
Why?
| | Cell Nucleus | 2 | 1985 | 584 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2009 | 89 | 0.020 |
Why?
| | Transplantation Chimera | 1 | 2008 | 57 | 0.020 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 1 | 2008 | 46 | 0.020 |
Why?
| | Eosinophils | 2 | 2004 | 319 | 0.020 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2008 | 25 | 0.020 |
Why?
| | Genes, Switch | 1 | 1988 | 6 | 0.020 |
Why?
| | Genes, Regulator | 1 | 1988 | 34 | 0.020 |
Why?
| | Antigens, Helminth | 1 | 2008 | 16 | 0.020 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2009 | 167 | 0.020 |
Why?
| | Influenza Vaccines | 1 | 2013 | 544 | 0.020 |
Why?
| | Cross-Priming | 1 | 2008 | 17 | 0.020 |
Why?
| | Shock, Septic | 1 | 1990 | 230 | 0.020 |
Why?
| | Schistosoma mansoni | 1 | 2008 | 45 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 8391 | 0.020 |
Why?
| | Mannose | 1 | 1987 | 23 | 0.020 |
Why?
| | Hexosaminidases | 1 | 1987 | 17 | 0.020 |
Why?
| | Introns | 1 | 1988 | 257 | 0.020 |
Why?
| | Nitrobenzenes | 3 | 1976 | 15 | 0.020 |
Why?
| | Biosensing Techniques | 1 | 2009 | 143 | 0.020 |
Why?
| | Yersinia enterocolitica | 1 | 2007 | 7 | 0.020 |
Why?
| | Antigens, CD1 | 1 | 2007 | 59 | 0.020 |
Why?
| | Leukemia P388 | 2 | 1984 | 7 | 0.020 |
Why?
| | Fluoresceins | 2 | 2004 | 48 | 0.020 |
Why?
| | Infection Control | 1 | 2009 | 174 | 0.020 |
Why?
| | Oligosaccharides | 1 | 1987 | 62 | 0.020 |
Why?
| | Genetic Variation | 2 | 1990 | 996 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2010 | 724 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2011 | 465 | 0.020 |
Why?
| | Hypersensitivity, Delayed | 3 | 1978 | 30 | 0.020 |
Why?
| | Pepsin A | 1 | 1986 | 18 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2006 | 51 | 0.020 |
Why?
| | Immunologic Techniques | 2 | 1983 | 36 | 0.020 |
Why?
| | Antibodies, Antinuclear | 1 | 2006 | 60 | 0.020 |
Why?
| | Health | 1 | 2007 | 81 | 0.010 |
Why?
| | Antigens, T-Independent | 2 | 1983 | 5 | 0.010 |
Why?
| | Oligonucleotides, Antisense | 2 | 2000 | 122 | 0.010 |
Why?
| | Half-Life | 2 | 1977 | 157 | 0.010 |
Why?
| | Proteinuria | 1 | 2006 | 103 | 0.010 |
Why?
| | Transgenes | 2 | 1997 | 178 | 0.010 |
Why?
| | Leukopoiesis | 1 | 2006 | 11 | 0.010 |
Why?
| | Peptide Hydrolases | 1 | 2006 | 105 | 0.010 |
Why?
| | Weight Loss | 1 | 1992 | 858 | 0.010 |
Why?
| | Kidney Glomerulus | 1 | 2006 | 129 | 0.010 |
Why?
| | Lymphoma | 5 | 1985 | 251 | 0.010 |
Why?
| | Body Weight | 1 | 1990 | 968 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 1985 | 197 | 0.010 |
Why?
| | Guinea Pigs | 2 | 1977 | 159 | 0.010 |
Why?
| | Prostaglandins E | 1 | 1985 | 33 | 0.010 |
Why?
| | Drug Synergism | 2 | 1983 | 354 | 0.010 |
Why?
| | Cytoplasm | 1 | 1985 | 253 | 0.010 |
Why?
| | Succinimides | 1 | 2004 | 21 | 0.010 |
Why?
| | Liposomes | 2 | 2002 | 269 | 0.010 |
Why?
| | Protein Denaturation | 1 | 1984 | 76 | 0.010 |
Why?
| | Immunoglobulin Allotypes | 1 | 1984 | 9 | 0.010 |
Why?
| | Immunoglobulin Light Chains | 1 | 1984 | 52 | 0.010 |
Why?
| | Freund's Adjuvant | 1 | 2004 | 17 | 0.010 |
Why?
| | Interphase | 2 | 2000 | 38 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2004 | 269 | 0.010 |
Why?
| | B-Cell CLL-Lymphoma 10 Protein | 1 | 2004 | 3 | 0.010 |
Why?
| | Albumins | 1 | 1984 | 120 | 0.010 |
Why?
| | Genetic Markers | 1 | 1985 | 340 | 0.010 |
Why?
| | Immunoglobulins | 1 | 1984 | 162 | 0.010 |
Why?
| | Antigens, Differentiation | 2 | 1997 | 75 | 0.010 |
Why?
| | Leukemia, Experimental | 1 | 1983 | 26 | 0.010 |
Why?
| | Isoelectric Focusing | 1 | 1983 | 30 | 0.010 |
Why?
| | Macrophage-Activating Factors | 1 | 1983 | 3 | 0.010 |
Why?
| | Sex Factors | 1 | 2010 | 2107 | 0.010 |
Why?
| | Hemagglutination Tests | 2 | 1973 | 7 | 0.010 |
Why?
| | Catalase | 1 | 2003 | 133 | 0.010 |
Why?
| | B-Cell Activation Factor Receptor | 1 | 2003 | 12 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 2 | 1999 | 175 | 0.010 |
Why?
| | United States | 1 | 2001 | 16136 | 0.010 |
Why?
| | Receptors, CCR5 | 1 | 2003 | 59 | 0.010 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 158 | 0.010 |
Why?
| | Lung Diseases | 1 | 2010 | 787 | 0.010 |
Why?
| | Fas Ligand Protein | 1 | 2003 | 61 | 0.010 |
Why?
| | Birds | 1 | 1983 | 87 | 0.010 |
Why?
| | Karyotyping | 1 | 1983 | 106 | 0.010 |
Why?
| | Neuropeptides | 1 | 2003 | 76 | 0.010 |
Why?
| | Incidence | 1 | 2010 | 2936 | 0.010 |
Why?
| | ZAP-70 Protein-Tyrosine Kinase | 1 | 2002 | 10 | 0.010 |
Why?
| | Lod Score | 1 | 2002 | 64 | 0.010 |
Why?
| | Graft Rejection | 1 | 1986 | 516 | 0.010 |
Why?
| | Lymphocyte Culture Test, Mixed | 3 | 1990 | 49 | 0.010 |
Why?
| | Ubiquitin C | 1 | 2001 | 3 | 0.010 |
Why?
| | Prognosis | 1 | 1991 | 4351 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2002 | 195 | 0.010 |
Why?
| | Fetal Blood | 1 | 1983 | 325 | 0.010 |
Why?
| | Sex Chromosome Aberrations | 1 | 1981 | 67 | 0.010 |
Why?
| | CD79 Antigens | 1 | 2001 | 17 | 0.010 |
Why?
| | Virus Assembly | 1 | 2002 | 81 | 0.010 |
Why?
| | Growth Inhibitors | 1 | 2001 | 39 | 0.010 |
Why?
| | Myoglobin | 1 | 2000 | 13 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 2001 | 238 | 0.010 |
Why?
| | Organ Specificity | 1 | 2001 | 307 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2001 | 275 | 0.010 |
Why?
| | Sequence Analysis | 1 | 2000 | 32 | 0.010 |
Why?
| | Lyme Disease Vaccines | 1 | 2000 | 3 | 0.010 |
Why?
| | Aspartic Acid | 1 | 2001 | 88 | 0.010 |
Why?
| | Up-Regulation | 1 | 2003 | 841 | 0.010 |
Why?
| | Lymphocyte Subsets | 1 | 2000 | 79 | 0.010 |
Why?
| | Biopolymers | 1 | 2000 | 31 | 0.010 |
Why?
| | Models, Biological | 2 | 2001 | 1761 | 0.010 |
Why?
| | Receptors, Interleukin-15 | 1 | 2000 | 3 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2007 | 980 | 0.010 |
Why?
| | Suppressor of Cytokine Signaling 1 Protein | 1 | 2000 | 12 | 0.010 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2000 | 58 | 0.010 |
Why?
| | Bacterial Vaccines | 1 | 2000 | 63 | 0.010 |
Why?
| | Staining and Labeling | 2 | 1980 | 148 | 0.010 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 1 | 2000 | 20 | 0.010 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2000 | 58 | 0.010 |
Why?
| | HLA-DRB1 Chains | 1 | 2000 | 109 | 0.010 |
Why?
| | Septins | 1 | 2000 | 43 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2000 | 317 | 0.010 |
Why?
| | Receptors, Interleukin-6 | 1 | 2000 | 49 | 0.010 |
Why?
| | STAT1 Transcription Factor | 1 | 2000 | 68 | 0.010 |
Why?
| | MAP Kinase Kinase Kinase 2 | 1 | 1999 | 12 | 0.010 |
Why?
| | Lyme Disease | 1 | 2000 | 58 | 0.010 |
Why?
| | GTP-Binding Proteins | 1 | 2000 | 150 | 0.010 |
Why?
| | Indicators and Reagents | 1 | 2000 | 105 | 0.010 |
Why?
| | Cell Lineage | 1 | 2001 | 377 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1999 | 95 | 0.010 |
Why?
| | Lymphocyte Transfusion | 1 | 1999 | 20 | 0.010 |
Why?
| | Multigene Family | 2 | 1991 | 210 | 0.010 |
Why?
| | Leukemia L1210 | 1 | 1999 | 7 | 0.010 |
Why?
| | Androstadienes | 1 | 1999 | 77 | 0.010 |
Why?
| | Lymphopenia | 1 | 1999 | 62 | 0.010 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 153 | 0.010 |
Why?
| | Free Radical Scavengers | 1 | 1999 | 81 | 0.010 |
Why?
| | Child, Preschool | 2 | 1993 | 11913 | 0.010 |
Why?
| | Tissue Distribution | 2 | 1993 | 334 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 134 | 0.010 |
Why?
| | Manganese | 1 | 1999 | 59 | 0.010 |
Why?
| | Metalloporphyrins | 1 | 1999 | 62 | 0.010 |
Why?
| | Cholic Acids | 1 | 1998 | 13 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2000 | 391 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 170 | 0.010 |
Why?
| | Detergents | 1 | 1998 | 42 | 0.010 |
Why?
| | Absorption | 2 | 1975 | 60 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 263 | 0.010 |
Why?
| | Membrane Potentials | 1 | 1999 | 278 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 1999 | 288 | 0.010 |
Why?
| | STAT3 Transcription Factor | 1 | 2000 | 214 | 0.010 |
Why?
| | Polysaccharides, Bacterial | 2 | 1975 | 70 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 1999 | 404 | 0.010 |
Why?
| | Histocompatibility | 1 | 1977 | 20 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2003 | 740 | 0.010 |
Why?
| | Isoantigens | 1 | 1977 | 17 | 0.010 |
Why?
| | Endocytosis | 1 | 1998 | 170 | 0.010 |
Why?
| | STAT6 Transcription Factor | 1 | 1997 | 25 | 0.010 |
Why?
| | Hybridization, Genetic | 1 | 1978 | 75 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 1999 | 384 | 0.010 |
Why?
| | Interleukins | 1 | 1999 | 248 | 0.010 |
Why?
| | Abatacept | 1 | 1997 | 56 | 0.010 |
Why?
| | Autoanalysis | 1 | 1977 | 8 | 0.010 |
Why?
| | Trypan Blue | 1 | 1977 | 5 | 0.010 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 1977 | 39 | 0.010 |
Why?
| | Whole-Body Irradiation | 1 | 1997 | 73 | 0.010 |
Why?
| | CTLA-4 Antigen | 1 | 1997 | 105 | 0.010 |
Why?
| | Gene Transfer Techniques | 1 | 1998 | 185 | 0.010 |
Why?
| | Infant | 1 | 1991 | 10114 | 0.010 |
Why?
| | Warfarin | 1 | 1978 | 179 | 0.010 |
Why?
| | Genetic Complementation Test | 2 | 1986 | 72 | 0.010 |
Why?
| | Antigen-Antibody Complex | 2 | 1987 | 70 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 823 | 0.010 |
Why?
| | Immunity, Mucosal | 1 | 1997 | 97 | 0.010 |
Why?
| | Sequence Homology | 1 | 1995 | 43 | 0.010 |
Why?
| | Radiation Effects | 1 | 1975 | 7 | 0.010 |
Why?
| | Mollusca | 1 | 1975 | 6 | 0.010 |
Why?
| | Surface Properties | 1 | 1976 | 384 | 0.010 |
Why?
| | Trachea | 1 | 1997 | 253 | 0.010 |
Why?
| | Skin Tests | 1 | 1975 | 94 | 0.010 |
Why?
| | Methods | 1 | 1974 | 68 | 0.010 |
Why?
| | Transferrin | 1 | 1993 | 48 | 0.010 |
Why?
| | Complement System Proteins | 2 | 1974 | 326 | 0.010 |
Why?
| | Hindlimb | 1 | 1974 | 128 | 0.010 |
Why?
| | Umbilical Cord | 1 | 1994 | 92 | 0.010 |
Why?
| | Transplantation Immunology | 1 | 1993 | 28 | 0.010 |
Why?
| | Cell Transplantation | 1 | 1993 | 39 | 0.010 |
Why?
| | Viral Plaque Assay | 1 | 1973 | 29 | 0.010 |
Why?
| | Immunoglobulin M | 1 | 1975 | 284 | 0.010 |
Why?
| | Bufo marinus | 1 | 1973 | 1 | 0.010 |
Why?
| | Antibodies, Anti-Idiotypic | 2 | 1983 | 50 | 0.010 |
Why?
| | Animals, Newborn | 2 | 1988 | 888 | 0.010 |
Why?
| | Blotting, Southern | 1 | 1993 | 82 | 0.010 |
Why?
| | Fetal Tissue Transplantation | 1 | 1992 | 33 | 0.010 |
Why?
| | Pedigree | 1 | 1994 | 512 | 0.010 |
Why?
| | Macaca mulatta | 1 | 1993 | 188 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1992 | 90 | 0.010 |
Why?
| | Disease | 1 | 1993 | 97 | 0.010 |
Why?
| | Models, Structural | 1 | 1991 | 40 | 0.010 |
Why?
| | Ionomycin | 1 | 1991 | 22 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 1991 | 128 | 0.010 |
Why?
| | Liver | 2 | 1992 | 1864 | 0.010 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1992 | 141 | 0.010 |
Why?
| | DNA Methylation | 1 | 1996 | 725 | 0.010 |
Why?
| | 6-Ketoprostaglandin F1 alpha | 1 | 1991 | 17 | 0.010 |
Why?
| | Calcimycin | 1 | 1991 | 36 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1991 | 197 | 0.010 |
Why?
| | Erythrocyte Transfusion | 1 | 1973 | 226 | 0.010 |
Why?
| | Endothelium, Vascular | 1 | 1997 | 952 | 0.000 |
Why?
| | Arthritis | 1 | 1991 | 97 | 0.000 |
Why?
| | Receptors, Leukocyte-Adhesion | 1 | 1990 | 2 | 0.000 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 1990 | 9 | 0.000 |
Why?
| | Thymidine | 1 | 1970 | 57 | 0.000 |
Why?
| | Oligonucleotide Probes | 1 | 1990 | 48 | 0.000 |
Why?
| | Amidohydrolases | 1 | 1990 | 31 | 0.000 |
Why?
| | Cytosine | 1 | 1970 | 49 | 0.000 |
Why?
| | RNA Splicing | 1 | 1991 | 288 | 0.000 |
Why?
| | Immunotherapy, Adoptive | 1 | 1993 | 356 | 0.000 |
Why?
| | Carbon Isotopes | 1 | 1970 | 143 | 0.000 |
Why?
| | Cricetulus | 1 | 1989 | 115 | 0.000 |
Why?
| | Reference Values | 1 | 1990 | 796 | 0.000 |
Why?
| | Extracellular Space | 1 | 1989 | 118 | 0.000 |
Why?
| | Gestational Age | 1 | 1992 | 990 | 0.000 |
Why?
| | Adrenergic beta-Antagonists | 1 | 1970 | 253 | 0.000 |
Why?
| | Cross-Linking Reagents | 1 | 1989 | 208 | 0.000 |
Why?
| | Microspheres | 1 | 1988 | 142 | 0.000 |
Why?
| | Bacteriophage lambda | 1 | 1988 | 89 | 0.000 |
Why?
| | Leukocyte Count | 1 | 1988 | 321 | 0.000 |
Why?
| | Enhancer Elements, Genetic | 1 | 1988 | 190 | 0.000 |
Why?
| | Glass | 1 | 1986 | 46 | 0.000 |
Why?
| | Staphylococcal Infections | 1 | 1990 | 397 | 0.000 |
Why?
| | Liver Transplantation | 1 | 1992 | 751 | 0.000 |
Why?
| | Immunoglobulin J-Chains | 1 | 1985 | 6 | 0.000 |
Why?
| | Transformation, Genetic | 1 | 1985 | 14 | 0.000 |
Why?
| | Mast-Cell Sarcoma | 1 | 1985 | 9 | 0.000 |
Why?
| | Bacteria | 1 | 1991 | 766 | 0.000 |
Why?
| | Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1984 | 1 | 0.000 |
Why?
| | Mesylates | 1 | 1984 | 7 | 0.000 |
Why?
| | Acetylglucosaminidase | 1 | 1984 | 8 | 0.000 |
Why?
| | Sezary Syndrome | 1 | 1984 | 45 | 0.000 |
Why?
| | Membranes, Artificial | 1 | 1984 | 67 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1984 | 316 | 0.000 |
Why?
| | Isoelectric Point | 1 | 1984 | 21 | 0.000 |
Why?
| | Thymus Neoplasms | 1 | 1984 | 30 | 0.000 |
Why?
| | Fixatives | 1 | 1983 | 13 | 0.000 |
Why?
| | Glutaral | 1 | 1983 | 14 | 0.000 |
Why?
| | Cell-Free System | 1 | 1983 | 54 | 0.000 |
Why?
| | Receptors, Antigen | 1 | 1983 | 15 | 0.000 |
Why?
| | Chemical Precipitation | 1 | 1983 | 39 | 0.000 |
Why?
| | Longitudinal Studies | 1 | 1990 | 3017 | 0.000 |
Why?
| | Tomography, X-Ray Computed | 1 | 1993 | 2786 | 0.000 |
Why?
| | X Chromosome | 1 | 1981 | 66 | 0.000 |
Why?
| | Pulmonary Alveoli | 1 | 1983 | 385 | 0.000 |
Why?
| | Brain | 1 | 1993 | 2991 | 0.000 |
Why?
| | Magnetic Resonance Imaging | 1 | 1993 | 3926 | 0.000 |
Why?
| | Polymers | 1 | 1983 | 488 | 0.000 |
Why?
| | Pregnancy | 1 | 1992 | 7230 | 0.000 |
Why?
| | Sarcoma, Experimental | 1 | 1974 | 6 | 0.000 |
Why?
| | Immunoglobulin Fragments | 1 | 1974 | 11 | 0.000 |
Why?
|
|
Kappler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|